D'ALESSANDRO, MIRIANA
 Distribuzione geografica
Continente #
NA - Nord America 806
AS - Asia 665
EU - Europa 447
SA - Sud America 36
AF - Africa 11
OC - Oceania 3
Totale 1.968
Nazione #
US - Stati Uniti d'America 758
BD - Bangladesh 318
IT - Italia 296
CN - Cina 99
SG - Singapore 90
HK - Hong Kong 82
FR - Francia 46
VN - Vietnam 37
DE - Germania 33
CA - Canada 31
BR - Brasile 26
PL - Polonia 20
GB - Regno Unito 15
NL - Olanda 14
MX - Messico 10
IN - India 7
AR - Argentina 4
ES - Italia 4
ID - Indonesia 4
KR - Corea 4
AU - Australia 3
BE - Belgio 3
IQ - Iraq 3
SA - Arabia Saudita 3
TR - Turchia 3
AZ - Azerbaigian 2
BG - Bulgaria 2
CO - Colombia 2
CR - Costa Rica 2
DZ - Algeria 2
EC - Ecuador 2
GT - Guatemala 2
JP - Giappone 2
KE - Kenya 2
KZ - Kazakistan 2
LT - Lituania 2
MA - Marocco 2
RS - Serbia 2
UA - Ucraina 2
ZA - Sudafrica 2
AT - Austria 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
CY - Cipro 1
CZ - Repubblica Ceca 1
GY - Guiana 1
HR - Croazia 1
IE - Irlanda 1
JM - Giamaica 1
KH - Cambogia 1
MG - Madagascar 1
MN - Mongolia 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
QA - Qatar 1
TH - Thailandia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 1.968
Città #
San Jose 180
New York 178
Hong Kong 82
Ashburn 79
Beijing 55
Singapore 45
Los Angeles 37
Buffalo 33
Rome 30
Milan 29
Frankfurt am Main 27
Naples 23
Hillsboro 18
Toronto 15
Warsaw 13
Florence 12
Turin 12
Vigonza 11
Hanoi 10
Ho Chi Minh City 10
Montreal 10
Santa Clara 10
Chicago 9
Bologna 8
Mexico City 8
Rimini 8
Dallas 7
Pasadena 6
Brescia 5
Charlotte 5
Genoa 5
San Diego 5
Catania 4
Fort Worth 4
Mumbai 4
Reston 4
San Mauro Pascoli 4
Seoul 4
Venice 4
Amsterdam 3
Baghdad 3
Bari 3
Council Bluffs 3
Da Nang 3
Orem 3
Padua 3
Palermo 3
Phoenix 3
Ravenna 3
Riyadh 3
Seattle 3
Thái Nguyên 3
Wroclaw 3
Alexandria 2
Arezzo 2
Atlanta 2
Bergamo 2
Brussels 2
Cagliari 2
Casarsa della Delizia 2
Cerdanyola del Vallès 2
Chennai 2
City of London 2
Greenville 2
Guatemala City 2
Guayaquil 2
Hackney 2
Houston 2
Jakarta 2
Las Vegas 2
Limburg an der Lahn 2
London 2
Madrid 2
Pescara 2
Philadelphia 2
Pisa 2
Rotterdam 2
San José 2
Shenzhen 2
Sorocaba 2
Sydney 2
São João de Meriti 2
Tampa 2
Verona 2
Abidjan 1
Acapulco de Juárez 1
Adel 1
Adelaide 1
Agadir 1
Agropoli 1
Alleur 1
Alliston 1
Amadora 1
Ancona 1
Annandale 1
Antananarivo 1
Arvada 1
Astana 1
Atripalda 1
Aversa 1
Totale 1.133
Nome #
Evaluation of short and long-term laboratory and instrumental findings in COVID-19 patients hospitalized in Tuscany 60
Hypercalciuria in Sarcoidosis: A Specific Biomarker With Clinical Utility 60
BAL Proteomic Signature of Lung Adenocarcinoma in IPF Patients and Its Transposition in Serum Samples for Less Invasive Diagnostic Procedures 58
Efficacy and safety of rituximab and low dosage of glucocorticoids for ANCA associated vasculitis interstitial lung disease: a proof-of-concept study 45
A Novel Ultrasonographic Anthropometric-Independent Measurement of Median Nerve Swelling in Carpal Tunnel Syndrome: The "Nerve/Tendon Ratio" (NTR) 41
Strain echocardiography is a promising tool for the prognostic assessment of sarcoidosis 38
Sarcoid Nodule or Lung Cancer? A High-Resolution Computed Tomography-Based Retrospective Study of Pulmonary Nodules in Patients with Sarcoidosis 35
Retrospective Study on the Features and Outcomes of a Tuscany COVID-19 Hospitalized Patients Cohort: Preliminary Results 35
Evaluation of multiple-flows exhaled nitric oxide and its clinical significance in severe asthmatic patients treated with biologics: a prospective real-life study 34
A Precision Surgery Framework for Lung Resection: Robotic, Video-Assisted, and Open Segmentectomy 28
Whole-genome sequencing reveals host factors underlying critical COVID-19 27
A Comprehensive Review of Sarcoidosis Diagnosis and Monitoring for the Pulmonologist 26
The Effects of Interstitial Lung Diseases on Alveolar Extracellular Vesicles Profile: A Multicenter Study 25
Assessing Short- and Medium-Term Outcomes of Lung Transplantation in Elderly Recipients: A Comparative Age-Based Analysis 25
The effectiveness of nintedanib in patients with idiopathic pulmonary fibrosis, familial pulmonary fibrosis and progressive fibrosing interstitial lung diseases: a real-world study 23
Mepolizumab and Benralizumab in Severe Eosinophilic Asthma: Preliminary Results of a Proteomic Study 23
KL-6 in ANCA-Associated Vasculitis Patients with and without ILD: A Machine Learning Approach 22
Galactin-1, 3 and 9: Potential biomarkers in idiopathic pulmonary fibrosis and other interstitial lung diseases 22
Extracellular Vesicles in Pulmonary Fibrosis Models and Biological Fluids of Interstitial Lung Disease Patients: A Scoping Review 21
Serum CD59: a novel biomarker of idiopathic pulmonary fibrosis? 20
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 19
From Prognostic Marker to Therapeutic Agent: The Role of Nitric Oxide in Lung Cancer 19
Efficacy and Safety of Upadacitinib in Rheumatoid Arthritis: Real-Life Experience from a Prospective Longitudinal Multicentric Study 19
Adding pieces to the puzzle: IL-33 contribution to fibrogenesis in chronic lung allograft dysfunction 18
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients 18
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 18
An explainable model of host genetic interactions linked to COVID-19 severity 18
Efficacy and safety of a step-down regimen of low dosage of glucocorticoids combined with early administration of synthetic or biologic immunosuppressants in anti-synthetase syndrome: A pilot study 18
Systematic review and metanalysis of oncomarkers in ipf patients and serial changes of oncomarkers in a prospective italian real-life case series 18
Extracellular Vesicle Surface Signatures in IPF Patients: A Multiplex Bead-Based Flow Cytometry Approach 17
Altered serum concentrations of IL-8, IL-32 and IL-10 in patients with lung impairment 6 months after COVID-19 16
Alveolar nitric oxide is related to periostin levels in idiopathic pulmonary fibrosis 16
Online survey on existing sarcoidosis registries and biobanks: An ERN lung initiative 16
Adhesion molecules and T cell imbalance in severe eosinophilic asthma: Insights from anti-IL-5R treatment 16
A multicenter approach to evaluate omalizumab effectiveness in Samter’s triad 15
Panel of serum biomarkers for differential diagnosis of idiopathic interstitial lung disease and interstitial lung disease-secondary to systemic autoimmune rheumatic disease 15
Peripheral biomarkers' panel for severe COVID-19 patients 15
AB0611 Neutrophil extracellular traps and interstitial lung disease in ANCA-associated vasculitis: a scoping review 15
Real-life comparison between pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis 15
Adiponectin and leptin levels in idiopathic pulmonary fibrosis: A new method for BAL and serum assessment 14
A Comprehensive Evaluation of Mepolizumab Effectiveness in a Real-Life Setting 14
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 14
Beyond inflammation: alarmins as critical drivers of pulmonary fibrosis 14
Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy 13
Accuracy of power Doppler ultrasonography in the diagnosis and monitoring of idiopathic inflammatory myopathies 13
A real-life experience with ImmunoCAP ISAC: the advantages of a new diagnostic method 13
Comparative Serum Protein Profiles in IPF Patients Before and After Nintedanib Therapy 13
Effects of rituximab therapy on B cell differentiation and depletion 13
A multicenter study of extracellular vesicles profile in bronchoalveolar lavage from patients affected by IPF, HP and sarcoidosis 13
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis 13
Prognostic role of KL-6 in SSc-ILD patients with pleuroparenchymal fibroelastosis 13
POS0823 KL-6 IN ANCA-ASSOCIATED VASCULITIS PATIENTS WITH AND WITHOUT ILD: A MACHINE LEARNING APPROACH 13
Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis 13
Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies 13
Anti-Cytosolic 5′-Nucleotidase 1A in the Diagnosis of Patients with Suspected Idiopathic Inflammatory Myopathies: An Italian Real-Life, Single-Centre Retrospective Study 13
BAL and serum multiplex lipid profiling in idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis 13
Alveolar nitric oxide as a biomarker of COVID-19 lung sequelae: A pivotal study 12
Immune-Checkpoint expression on CD4, CD8 and NK cells in blood, BAL and lymph nodes of sarcoidosis 12
Natural killer T-cells in asthma pathogenesis and treatment: old problems and future perspectives 12
Regulatory T Cell Phenotype Related to Cytokine Expression Patterns in Post-COVID-19 Pulmonary Fibrosis and Idiopathic Pulmonary Fibrosis 12
Adaptive immune system in pulmonary sarcoidosis - comparison of peripheral and alveolar biomarkers 12
Alteration of Immune-checkpoint after specific stimulation with CMV antigens in pre-LTx patients 12
Real-life experience of severe asthma patients on Dupilumab treatment in Pordenone’s Hospital 12
Serial autoantibody detection in interstitial lung diseases: should they be repeated at follow-up? 12
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 12
Long-Term Follow-Up of Patients With Idiopathic Pulmonary Fibrosis Treated With Pirfenidone or Nintedanib: A Real-Life Comparison Study 11
CD103 Expression on Regulatory and Follicular T Cells in Lymph Nodes, Bronchoalveolar Lavage Fluid and Peripheral Blood of Sarcoidosis Patients 11
Diagnostic Value of Krebs von den Lungen (KL-6) for Interstitial Lung Disease: A European Prospective Cohort 11
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 11
Uncovering Sex and Gender Differences in Sarcoidosis: A Systematic Review of Current Evidence 11
Right cardiac involvement in lung diseases: a multimodality approach from diagnosis to prognostication 11
Neutrophil-to-lymphocyte ratio in IPF patients: a novel prognostic biomarker? 11
Valutazione prognostica della Siero Amiloide A in pazienti affetti da Fibrosi Polmonare Idiopatica 10
POS0871 diagnostic accuracy og power doppler ultrasonography for the diagnosis of idiopathic inflammmatory myopathies 10
A first update on mapping the human genetic architecture of COVID-19 10
Combined Sarcoidosis and Idiopathic Pulmonary Fibrosis (CSIPF): A New Phenotype or a Fortuitous Overlap? Scoping Review and Case Series 10
Immunological Similarities and Differences between Post-COVID-19 Lung Sequelae and Idiopathic Pulmonary Fibrosis 10
Relapses of idiopathic inflammatory myopathies after vaccination against COVID19: a real-life Italian study 10
Benralizumab affects NK cell maturation and proliferation in severe asthmatic patients 10
Safety and uptake of solid lipid nanoparticles by airway epithelial cells: an in vitro study 10
Nk and t cell immunological signatures in hospitalized patients with covid-19 9
PD-1/TIGIT axis: a novel therapeutic target? 9
Role of BAL and Serum Krebs von den Lungen-6 (KL-6) in Patients with Pulmonary Fibrosis 9
The impact of anti-IL5 therapies on patients with severe eosinophilic asthma: a proteomic approach 9
The value of urinary calcium as biomarker in chronic sarcoidosis 9
The Role of Galectins in Chronic Lung Allograft Dysfunction 9
The effect of anti-IL5 monoclonal antibodies on regulatory and effector T cells in severe eosinophilic asthma 9
Predictive role of natural killer cells in bronchoalveolar lavage fluid of patients with sarcoidosis 9
Multiple-flows exhaled nitric oxide for the detection and severity assessment of post-COVID19 lung sequelae 8
Ceruloplasmin and oxidative stress in severe eosinophilic asthma patients treated with Mepolizumab and Benralizumab 8
Interpretation and clinical significance of multiple-flows exhaled nitric oxide in severe asthma framework 8
The role of the combination of echo-HRCT score as a tool to evaluate the presence of pulmonary hypertension in idiopathic pulmonary fibrosis 8
BAL as a research tool 8
Prognostic evaluation of alveolar concentration of nitric oxide, serum periostin and CD59 in patients with idiopathic pulmonary fibrosis 8
Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review 8
Siero Amiloide A: nuovo potenziale biomarcatore di Fibrosi Polmonare Idiopatica 8
Pathogen-sugar interactions revealed by universal saturation transfer analysis 8
SARS-CoV-2 and Dysphagia: A Retrospective Analysis of COVID-19 Patients with Swallowing Disorders 8
WES profiling of COVID-19 8
Strain echocardiography for the prognostic estimation of patients with sarcoidosis 8
Totale 1.647
Categoria #
all - tutte 20.358
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.358


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202513 0 0 0 0 0 0 0 0 3 8 2 0
2025/20262.197 9 3 11 14 5 1 93 465 284 505 390 417
Totale 2.210